company background image
BELL

Belluscura AIM:BELL Stock Report

Last Price

UK£0.71

Market Cap

UK£87.3m

7D

8.4%

1Y

-30.7%

Updated

05 Dec, 2022

Data

Company Financials +
BELL fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance0/6
Financial Health3/6
Dividends0/6

BELL Stock Overview

Belluscura plc develops and commercialize oxygen related medical device products.

Belluscura plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Belluscura
Historical stock prices
Current Share PriceUK£0.71
52 Week HighUK£1.52
52 Week LowUK£0.45
Beta0
1 Month Change17.36%
3 Month Change-5.96%
1 Year Change-30.73%
3 Year Changen/a
5 Year Changen/a
Change since IPO33.96%

Recent News & Updates

Recent updates

Shareholder Returns

BELLGB Medical EquipmentGB Market
7D8.4%0.2%1.1%
1Y-30.7%-12.6%-6.6%

Return vs Industry: BELL underperformed the UK Medical Equipment industry which returned -10.1% over the past year.

Return vs Market: BELL underperformed the UK Market which returned -6% over the past year.

Price Volatility

Is BELL's price volatile compared to industry and market?
BELL volatility
BELL Average Weekly Movement9.9%
Medical Equipment Industry Average Movement6.4%
Market Average Movement5.8%
10% most volatile stocks in GB Market11.1%
10% least volatile stocks in GB Market2.9%

Stable Share Price: BELL is more volatile than 75% of UK stocks over the past 3 months, typically moving +/- 10% a week.

Volatility Over Time: BELL's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of UK stocks.

About the Company

FoundedEmployeesCEOWebsite
201511Bob Raukerhttps://www.belluscura.com

Belluscura plc develops and commercialize oxygen related medical device products. The company offers X-PLO2R, a modular portable oxygen concentrator. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.

Belluscura plc Fundamentals Summary

How do Belluscura's earnings and revenue compare to its market cap?
BELL fundamental statistics
Market CapUK£87.34m
Earnings (TTM)-UK£6.02m
Revenue (TTM)UK£805.40k

108.5x

P/S Ratio

-14.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
BELL income statement (TTM)
RevenueUS$982.06k
Cost of RevenueUS$3.21m
Gross Profit-US$2.23m
Other ExpensesUS$5.11m
Earnings-US$7.34m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.06
Gross Margin-226.78%
Net Profit Margin-747.21%
Debt/Equity Ratio0.7%

How did BELL perform over the long term?

See historical performance and comparison